# Gilead Sciences (GILD) P/E ratio: 18.1× in 2025

URL: https://funkfolio.com/stock/GILD/pe-ratio

> Gilead Sciences (GILD) P/E ratio was 18.1× in fiscal 2025, down 92.6% from fiscal 2024. 18 fiscal years of history in a chart and a table.

---

## Gilead Sciences (GILD) P/E ratio

**P/E ratio · fiscal 2025:** 18.1× at Dec 31, 2025

The P/E ratio of Gilead Sciences (GILD) was 18.1× at the end of fiscal 2025 (December 31, 2025). That is 92.6% lower than the 243.1× of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **P/E ratio, fiscal 2025:** 18.1×
- **Change on fiscal 2024:** −92.6%
- **Highest on record:** 243.1× fiscal 2024
- **Lowest on record:** 7.2× fiscal 2016
- **Fiscal years on record:** 18 2007–2025

Figures as of 18 Nov 2026, 12:18 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Gilead Sciences P/E ratio, in more detail

Across the 18 fiscal year-ends on record (2007–2025), the highest was 243.1× in fiscal 2024 and the lowest 7.2× in fiscal 2016.

### P/E ratio at each fiscal year-end

### Gilead Sciences P/E ratio, year by year

Gilead Sciences (GILD) P/E ratio by fiscal year

| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
| --- | --- | --- | --- | --- | --- |
| 2025 | 18.1× | 92.6% down | Dec 31, 2025 | $122.74 | $6.78 |
| 2024 | 243.1× | 1,250.3% up | Dec 31, 2024 | $92.37 | $0.38 |
| 2023 | 18.0× | 23.7% down | Dec 31, 2023 | $81.01 | $4.50 |
| 2022 | 23.6× | 60.1% up | Dec 31, 2022 | $85.85 | $3.64 |
| 2021 | 14.7× | — | Dec 31, 2021 | $72.61 | $4.93 |
| 2020 | — | — | Dec 31, 2020 | $58.26 | $0.10 |
| 2019 | 15.4× | 2.7% up | Dec 31, 2019 | $64.98 | $4.22 |
| 2018 | 15.0× | 26.5% down | Dec 31, 2018 | $62.55 | $4.17 |
| 2017 | 20.4× | 183.3% up | Dec 31, 2017 | $71.64 | $3.51 |
| 2016 | 7.2× | 15.2% down | Dec 31, 2016 | $71.61 | $9.94 |
| 2015 | 8.5× | 33.8% down | Dec 31, 2015 | $101.19 | $11.91 |
| 2014 | 12.8× | 69.1% down | Dec 31, 2014 | $94.26 | $7.35 |
| 2013 | 41.5× | 85.3% up | Dec 31, 2013 | $75.10 | $1.81 |
| 2012 | 22.4× | 93.7% up | Dec 31, 2012 | $36.72 | $1.64 |
| 2011 | 11.6× | 5.9% up | Dec 31, 2011 | $20.47 | $1.77 |
| 2010 | 10.9× | 28.9% down | Dec 31, 2010 | $18.12 | $1.66 |
| 2009 | 15.3× | 38.2% down | Dec 31, 2009 | $21.64 | $1.41 |
| 2008 | 24.8× | 11.5% down | Dec 31, 2008 | $25.57 | $1.03 |
| 2007 | 28.1× | — | Dec 31, 2007 | $23.00 | $0.82 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

### How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

### P/E ratio at health care companies of similar size

P/E ratio of Gilead Sciences and comparable companies

| Company | P/E ratio |
| --- | --- |
| [Thermo Fisher Scientific TMO](https://funkfolio.com/stock/TMO/pe-ratio) | 36.2× |
| [Amgen AMGN](https://funkfolio.com/stock/AMGN/pe-ratio) | 26.5× |
| [Abbott Laboratories ABT](https://funkfolio.com/stock/ABT/pe-ratio) | 39.1× |
| [Novo Nordisk NVO](https://funkfolio.com/stock/NVO/pe-ratio) | 10.3× |
| [Pfizer PFE](https://funkfolio.com/stock/PFE/pe-ratio) | 40.7× |

Price over the last twelve months' earnings per share, as the market data feed reports it.

### Gilead Sciences, figure by figure

- [Gilead Sciences market cap](https://funkfolio.com/stock/GILD/market-cap)
- [Gilead Sciences revenue](https://funkfolio.com/stock/GILD/revenue)
- [Gilead Sciences earnings](https://funkfolio.com/stock/GILD/earnings)
- [Gilead Sciences earnings per share (EPS)](https://funkfolio.com/stock/GILD/eps)
- [Gilead Sciences P/S ratio](https://funkfolio.com/stock/GILD/ps-ratio)
- [Gilead Sciences P/B ratio](https://funkfolio.com/stock/GILD/pb-ratio)
- [Gilead Sciences free cash flow](https://funkfolio.com/stock/GILD/free-cash-flow)
- [Gilead Sciences operating margin](https://funkfolio.com/stock/GILD/operating-margin)
- [Gilead Sciences dividend](https://funkfolio.com/stock/GILD/dividend)
- [Gilead Sciences shares outstanding](https://funkfolio.com/stock/GILD/shares-outstanding)
- [Gilead Sciences total debt](https://funkfolio.com/stock/GILD/total-debt)
- [Gilead Sciences cash on hand](https://funkfolio.com/stock/GILD/cash)
- [Gilead Sciences total assets](https://funkfolio.com/stock/GILD/total-assets)
- [Gilead Sciences return on equity (ROE)](https://funkfolio.com/stock/GILD/roe)
- [Gilead Sciences return on invested capital (ROIC)](https://funkfolio.com/stock/GILD/roic)

[Gilead Sciences (GILD) overview: price, valuation and scorecard](https://funkfolio.com/stock/GILD) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Gilead Sciences P/E ratio: questions and answers

**What is Gilead Sciences's P/E ratio?**

The P/E ratio of Gilead Sciences (GILD) was 18.1× at the end of fiscal 2025 (December 31, 2025). That is 92.6% lower than the 243.1× of fiscal 2024.

**What are the highest and lowest P/E ratio figures on record for Gilead Sciences?**

Across the 18 fiscal year-ends on record (2007–2025), the highest was 243.1× in fiscal 2024 and the lowest 7.2× in fiscal 2016.

**How is Gilead Sciences's P/E ratio calculated?**

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Gilead Sciences it is on record here for 18 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/E ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [PEG ratio: P/E adjusted for growth, and its limits](https://funkfolio.com/learn/stocks/peg-ratio)

  The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Gilead Sciences (GILD) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/GILD/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.
